A RANDOMIZED TRIAL OF LOW-DOSE BEVACIZUMAB VERSUS LASER FOR TYPE 1 RETINOPATHY OF PREMATURITY (ROP3)

Project: Research project

Project Details

StatusActive
Effective start/end date9/1/22 → 12/31/23

Funding

  • Jaeb Center for Health Research (Peyton AGMT 11/29/22//5UG1EY011751-26)
  • National Eye Institute (Peyton AGMT 11/29/22//5UG1EY011751-26)